HIGH-VOLUME · SEX-BALANCED
dulaglutide Side Effects
dulaglutide (also sold as Trulicity) is HIGH-VOLUME in this FAERS book #88 of 524 by FAERS report count. Signature opener: SEX-BALANCED - 58% of sex-coded reports are female (44,406 F / 32,394 M).
Data updated 2026-05-15
- 85,635
- FAERS reports
FAERS voluntary reports, 2011 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
dulaglutide reporting skew - 58% of sex-coded reports are female (44,406 F / 32,394 M). Volume band HIGH-VOLUME #88 of 524 by FAERS report count; caseload CASELOAD.
High-report extract for dulaglutide (Trulicity): 85,635 FAERS rows (2011-2025). Top named reactions: NAUSEA, INJECTION SITE PAIN, BLOOD GLUCOSE INCREASED. Outcome stamps DEATH-MARKED · HOSP-MID · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2011–2025). Stamps CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
NAUSEA leads 9,986 of 85,635 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (17,698 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 1,580 reports (1.8% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 722 |
| PANCREATIC CARCINOMA | 58 |
| LACTIC ACIDOSIS | 55 |
| MYOCARDIAL INFARCTION | 55 |
| COVID-19 | 51 |
| NAUSEA | 47 |
| PNEUMONIA | 46 |
| CARDIAC ARREST | 42 |
| VOMITING | 42 |
| DECREASED APPETITE | 39 |
| ACUTE KIDNEY INJURY | 38 |
| DIARRHOEA | 36 |
| CARDIO-RESPIRATORY ARREST | 33 |
| DYSPNOEA | 31 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 30 |
| PANCREATITIS | 29 |
| SEPSIS | 28 |
| FATIGUE | 26 |
| SEPTIC SHOCK | 26 |
Reactions in Hospitalization Reports
Hospitalization mid-share (10,007, 11.7%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| NAUSEA | 1,419 |
| VOMITING | 1,402 |
| DIARRHOEA | 1,078 |
| IMPAIRED GASTRIC EMPTYING | 743 |
| BLOOD GLUCOSE INCREASED | 717 |
| ABDOMINAL PAIN | 676 |
| DEHYDRATION | 668 |
| PANCREATITIS | 585 |
| CONSTIPATION | 509 |
| DECREASED APPETITE | 502 |
| ACUTE KIDNEY INJURY | 471 |
| FALL | 394 |
| WEIGHT DECREASED | 378 |
| DIABETIC KETOACIDOSIS | 357 |
| ABDOMINAL PAIN UPPER | 330 |
| DYSPNOEA | 321 |
| COVID-19 | 306 |
| PNEUMONIA | 291 |
| FATIGUE | 288 |
How to read dulaglutide FAERS figures (CASELOAD · DEATH-MARKED · HOSP-MID)
FAERS holds 85,635 voluntary reports linked to dulaglutide (Trulicity), 2011-2025. Death is listed on 1,580 (1.8%). Hospitalization appears on 10,007 (11.7%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; SEX-BALANCED is the page opener, not a per-patient risk.
Read with dulaglutide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 84,725 FAERS cases (Δ 910 lighter vs dulaglutide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 83,781 FAERS cases (Δ 1,854 lighter vs dulaglutide); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 87,759 FAERS cases (Δ 2,124 heavier vs dulaglutide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 83,476 FAERS cases (Δ 2,159 lighter vs dulaglutide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 60.3 pp vs dulaglutide's DEATH-MARKED): CASELOAD · HOSP-MID.
dulaglutide sits in CASELOAD; high report volume tracks exposure and reporting culture more than per-patient risk. Methodology states the de-dup rules.